Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Acute Lymphoblastic Leukemia Therapies Informed by Genomic Analyses

NCT02580981 is registered in ClinicalTrials.gov with New Mexico Cancer Research Alliance as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02580981 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Acute Lymphoblastic Leukemia Therapies Informed by Genomic Analyses
Lead sponsor
New Mexico Cancer Research Alliance
Phase
Not applicable
Overall status
Terminated
Start date
July 28, 2016
Completion date
October 20, 2022
Enrollment
21 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

leukemia, acute lymphoblastic